Nikhil Adhesives has reported a significant increase in its earnings before interest, taxes, depreciation, and amortization (EBITDA) for the second quarter (Q2) of the current fiscal year. EBITDA rose to…
Browsing: Earnings Reports
Windlas Biotech, a leading pharmaceutical formulations contract development and manufacturing organization (CDMO), has reported its Q2 FY24 results. The company’s EBITDA for Q2 FY24 stood at 230 million rupees, compared…
Hyundai Motor India has reported a year-over-year (YOY) decline in both its earnings before interest, taxes, depreciation, and amortization (EBITDA) and EBITDA margin for the second quarter of the year.…
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its generic version of Ivabradine tablets in 5 mg and 7.5 mg dosages. This medication…
Crest Ventures, a non-banking finance company (NBFC) operating primarily in real estate and financial services, has reported a significant drop in its consolidated net profit for the second quarter of…
Infibeam Avenues, a leading Indian fintech company, has announced its second-quarter results for the fiscal year 2023-24. The company reported a year-on-year (YOY) increase in earnings before interest, taxes, depreciation,…
Wonder Electricals Limited (WEL) has reported a significant jump in its earnings before interest, taxes, depreciation, and amortization (EBITDA) for the second quarter of the fiscal year. EBITDA surged to…
Lyka Labs, a pharmaceutical company, has announced a consolidated net profit of ₹21 million for the second quarter of the current fiscal year. This marks a significant turnaround from the…
Zydus Lifesciences, an Indian pharmaceutical company, has reported a 21.9% quarter-over-quarter (QoQ) decline in its US formulations sales for the first quarter of the fiscal year 2025 (Q1 FY25). The…
Jyothy Labs, a leading Indian FMCG company known for brands like Ujala, Henko, and Pril, has reported a marginal year-on-year (YOY) revenue increase in the second quarter. Revenue for Q2…